700 patients110,866 observations180 daysLIVE

Patient P-02479

Synthetic patientMETA-24 · Day 161 · 45–54 · F · baseline S13Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Favorable
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
11%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S13
  2. Day 15 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 22 DT-01 recommendedDosing / Timing Recommendation DT-01
  4. Day 23 Patient acceptedStarted DT-01 in the companion
  5. Day 28 GI symptom burden −14% vs expectedDosing / Timing Recommendation DT-01
  6. Day 34 Tolerance state changedUnstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 15.

Primary contributors, last 14 days
  • GI instability-21
  • Inflammatory activity-14
  • Nutritional resilience+7
  • Treatment adherence+3

What helped?

  • Dosing / Timing Recommendation DT-01Day 22
    Result: symptom burden −14%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes
Wearable
88 min
improving · +4.1 vs previous 14 d
Sleep duration
Wearable
6.1 h
stable · -0.2 vs previous 14 d
Energy level
Daily log
5.5/10
stable · -0.1 vs previous 14 d
Steps
Wearable
9,685
improving · +409 vs previous 14 d
GI burden
Companion
22/100
improving · -2.8 vs previous 14 d
Adherence
Companion
95.2 %
stable · +2.5 vs previous 14 d
Sleep quality
Wearable
49.4/100
worsening · -3.4 vs previous 14 d
Glucose, CGM daily mean
CGM
138 mg/dL
stable · +1.9 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →

Heading towards restoration · 67 from the failing basin, 31 from restoration.

Good elements to keep
  • Dosing / Timing Recommendation DT-01
    intervention · steering +11.2
  • Protein (supports)
    perturbation · steering +7.4
  • Protein
    supporter · GI -4.4 next day
Main detractors to watch
  • Low butyrate capacity
    hidden · steering -17.5
  • Dietary fat load
    perturbation · steering -9
  • Simple carbohydrates
    perturbation · steering -8.1
  • Rapid metabolizer
    hidden · steering -8
  • Dietary fat load
    detractor · GI +5 next day
  • Simple carbohydrates
    detractor · GI +4.4 next day
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Dietary fat load
    +5detractor · 95%
  • Simple carbohydrates
    +4.4detractor · 95%
  • Protein
    -4.4supporter · 95%
  • Ultra-processed food
    +2.8detractor · 61%
  • Alcohol
    -2.1no signal · 45%
  • Caffeine
    -1.1no signal · 20%
  • Insoluble fibre
    -0.3no signal · 15%
  • Histamine load
    +0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Butyrate / short-chain fatty acid production 60
    • MicrobiomeButyrate capacity 37/100
    • MicrobiomeF. prausnitzii depleted
  • Mucosal barrier integrity 40
    • MicrobiomeAkkermansia low → thinner mucus layer
    • WearableSleep 6.1 h, below personal baseline
  • Autonomic recovery 20
    • WearableShort sleep window
DNA
Fictional pharmacogenomic panel
  • CYP2D6 Rapid metabolizer
    Expected exposure
Microbiome
Shannon diversity 2.5 · butyrate capacity 37/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisNormal
  • Bifidobacterium longumLow
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
62 ms
Sleep
6.0 h
Steps
9,367
Resting HR
58 bpm
Daily log: GI score 22, nutritional resilience 66, adherence 95.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
  • Log the daily check-in; one line is enough
  • Keep the current walking rhythm
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the dose at the same time relative to your evening meal
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0236532%S0872
P-0269833%S06ME-01improved71
P-0233533%S0470
P-0221434%S08SC-12no change69
P-0235634%S0869
P-0208333%S1369
P-0229333%S15HY-01no change68
P-0244234%S1468
P-0246335%S1868
P-0263734%S1167
P-0263433%S0767
P-0219432%S0367